Quick answer: The clearest signs depression is getting worse include losing interest in things that used to matter, feeling emotionally flat instead of just sad, struggling more with sleep or appetite, withdrawing further from people, and finding it harder to function at work or home. These changes usually build up slowly rather than hitting all […]

Yes, an antidepressant can stop working even after months or years of success. This is a recognized clinical phenomenon, sometimes called antidepressant tachyphylaxis or the “poop-out effect.” It happens when the brain adjusts to a medication over time, causing symptoms to return or treatment benefits to fade despite consistent dosing. It does not mean a […]

Short answer: Most people who respond to TMS notice small, quiet shifts before anything dramatic happens – sleeping a little easier, getting through a morning without dread, answering a text instead of letting it sit. These changes usually show up between weeks two and four, often before mood itself feels different. So if you’re trying […]

According to a 2025 individual participant data analysis published in eClinicalMedicine (The Lancet), intranasal esketamine does not appear to be more effective than TMS for treatment-resistant depression; TMS was found to be similarly effective, or potentially even superior, to Spravato across key outcomes. That is a striking finding, especially for patients who assume a medication-based […]

This happens when the brain’s stress and emotion systems become overloaded, leaving a person disconnected from both positive and negative feelings. It’s most commonly linked to depression, anxiety disorders, PTSD, and burnout, and it usually works as a protective response rather than a personal failing. It can show up as flat mood, dulled reactions to […]

According to a systematic review and meta-analysis published in the Journal of Affective Disorders (Rakesh et al., August 2024), According to a naturalistic study published in PLOS ONE (PubMed, 2022), both TMS and intramuscular ketamine produced equally significant reductions in depression and anxiety symptoms in treatment-resistant patients, with no statistically meaningful difference in response or […]

Chronic emptiness is a lasting sense of emotional flatness that shows up after the nervous system has been under pressure for too long. It is not sadness – it is closer to a shutdown, where the brain quiets emotional signals to conserve energy. People who chronically feel empty often describe going through daily life without […]

According to a systematic review and meta-analysis published in the Journal of Affective Disorders (Rakesh et al., August 2024), active TMS combined with antidepressant medication produced significantly greater improvement in major depressive disorder than sham TMS combined with the same medications, with a large effect size that held across multiple trials. That finding points to […]

In everyday clinical practice, the TMS therapy success rate typically falls between 50% and 65% for meaningful symptom response, with remission – meaning symptoms drop to a minimal or non-existent level – occurring in roughly 30% to 40% of patients. These figures come from real-world data collected across treatment centers, not just controlled trials, which […]

According to the U.S. Food and Drug Administration, TMS has received FDA clearance for major depressive disorder, obsessive-compulsive disorder, smoking cessation, and anxious depression, while MeRT, as of 2025, has not yet received FDA clearance for any specific condition, with its pivotal PTSD trial still under review (FDA Device Database, 2025). That single fact frames […]